Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DarioHealth Corp.DRIO · Entity 7024 | Director | March 01, 2020 | March 05, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DarioHealth Corp.
Report date March 01, 2020 · Filed March 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.30 · Expires 2026-03-01 | Direct | 90,000 |
Reported balance
After 2020-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-03-01 · Grant · Acquired 90,000 · Balance 90,000 F1: The option was granted on March 1, 2020 and provides for vesting as follows: (i) 15,000 shares of common stock vest on six month anniversary of the date of grant; and (ii) the balance shall vest ratably over ten equal quarterly installments following the six month anniversary of the date of grant, subject to the Reporting Person's continued services with the company. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted on March 1, 2020 and provides for vesting as follows: (i) 15,000 shares of common stock vest on six month anniversary of the date of grant; and (ii) the balance shall vest ratably over ten equal quarterly installments following the six month anniversary of the date of grant, subject to the Reporting Person's continued services with the company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2020 Filed Mar 5, 2020 16:57 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 90,000 | Not disclosed Strike: $7.30 | Not disclosed |
DisclosureSEC source: 0001104659-20-029753 · tm2011884d2_4.xml · derivative · entry 1 Shemmer Yadin · CIK 0001805082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2026-03-01 F1 · price: The option was granted on March 1, 2020 and provides for vesting as follows: (i) 15,000 shares of common stock vest on six month anniversary of the date of grant; and (ii) the balance shall vest ratably over ten equal quarterly installments following the six month anniversary of the date of grant, subject to the Reporting Person's continued services with the company. F1 · derivative.exercise_date: The option was granted on March 1, 2020 and provides for vesting as follows: (i) 15,000 shares of common stock vest on six month anniversary of the date of grant; and (ii) the balance shall vest ratably over ten equal quarterly installments following the six month anniversary of the date of grant, subject to the Reporting Person's continued services with the company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.